Loading...
XKRX
090370
Market cap25mUSD
Jul 24, Last price  
1,390.00KRW
1D
0.00%
1Q
-1.00%
Jan 2017
-93.33%
IPO
-99.39%
Name

MetaLabs Co Ltd

Chart & Performance

D1W1MN
P/E
175.76
P/S
0.90
EPS
7.91
Div Yield, %
—
Shrs. gr., 5y
20.18%
Rev. gr., 5y
-15.09%
Revenues
38.36b
+77.60%
96,691,754,000115,633,244,000127,014,045,000124,493,331,000151,702,804,810145,623,074,000141,412,155,020127,864,761,590115,996,783,08092,066,961,94026,832,431,61047,375,133,98086,896,351,29083,353,809,65039,300,730,76022,659,042,21021,598,887,65038,359,458,270
Net income
197m
P
11,167,976,0001,701,550,000-4,123,168,000-2,350,432,000478,478,000-26,417,144,000-11,079,980,270-4,037,119,140-36,710,092,120-39,219,756,780-37,939,377,530-13,521,275,940-25,362,334,390-19,340,233,270-16,200,774,560-12,812,632,080-7,299,953,580196,936,470
CFO
-3.83b
L+7,621.02%
-1,559,379,000-335,133,000-13,404,655,0002,222,974,000-4,021,706,910-8,870,478,8002,567,033,290-10,838,135,350-7,883,383,220-10,014,767,330-8,468,021,080-6,896,735,860-4,021,331,0201,363,610,6202,279,490,380447,640,150-49,571,895-3,827,453,540
Dividend
Dec 27, 201227.309 KRW/sh
Earnings
Aug 12, 2025

Profile

Metalabs Co., Ltd. primarily provides clothing in South Korea. It also manufactures and distributes prescription drugs, medical devices, and masks; develops peptide-based bio products; offers medical management services; and distributes cosmetics, as well as operates dating applications. The company was formerly known as Avista Inc. and changed its name to Metalabs Co., Ltd. in April 2018. Metalabs Co., Ltd. was founded in 2000 and is based in Seoul, South Korea.
URL
http://www.metalabs.co.kr/
IPO date
Dec 26, 2006
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
38,359,458
77.60%
21,598,888
-4.68%
22,659,042
-42.34%
Cost of revenue
33,646,065
20,989,081
17,247,553
Unusual Expense (Income)
NOPBT
4,713,393
609,806
5,411,489
NOPBT Margin
12.29%
2.82%
23.88%
Operating Taxes
(903,991)
(502,185)
(844,081)
Tax Rate
NOPAT
5,617,384
1,111,991
6,255,570
Net income
196,936
-102.70%
(7,299,954)
-43.03%
(12,812,632)
-20.91%
Dividends
Dividend yield
Proceeds from repurchase of equity
29,991,954
BB yield
-53.87%
Debt
Debt current
27,473,406
4,601,762
4,634,901
Long-term debt
16,744,448
27,905,697
2,372,574
Deferred revenue
Other long-term liabilities
2,509,221
2,142,907
397,029
Net debt
(25,245,812)
(51,438,768)
(39,516,877)
Cash flow
Cash from operating activities
(3,827,454)
(49,572)
447,640
CAPEX
(761,992)
(38,809,674)
(2,571,935)
Cash from investing activities
(12,664,383)
(27,254,926)
(27,950,546)
Cash from financing activities
16,523,997
26,934,004
18,340,992
FCF
12,432,723
2,526,697
(652,549)
Balance
Cash
1,701,297
1,719,136
17,139,629
Long term investments
67,762,368
82,227,091
29,384,723
Excess cash
67,545,692
82,866,283
45,391,400
Stockholders' equity
65,142,361
60,707,449
58,363,919
Invested Capital
58,123,537
46,473,879
38,865,877
ROIC
10.74%
2.61%
13.76%
ROCE
3.77%
0.56%
6.33%
EV
Common stock shares outstanding
24,930
24,902
22,769
Price
1,308.00
-41.21%
2,225.00
-9.00%
2,445.00
-47.92%
Market cap
32,608,363
-41.15%
55,406,125
-0.47%
55,670,369
-24.44%
EV
8,672,244
5,527,734
16,362,279
EBITDA
7,117,423
2,960,179
8,496,234
EV/EBITDA
1.22
1.87
1.93
Interest
2,458,889
812,098
2,098,727
Interest/NOPBT
52.17%
133.17%
38.78%